Related Experiment Video
Updated: Nov 7, 2025

07:52
Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation
Published on: June 17, 2013
40.0K
Transcranial direct current stimulation for treatment-resistant obsessive-compulsive disorder-A large case series
Abel Thamby1, Karthik Seshachala1, Lavanya Sharma1
1Department of Psychiatry, OCD Clinic, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.
Asian Journal of Psychiatry
|April 30, 2021
Summary
Transcranial direct current stimulation (tDCS) may offer benefits for some individuals with treatment-resistant obsessive compulsive disorder (OCD). This case series found that a proportion of patients experienced at least partial symptom improvement after tDCS treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Neuromodulation
Background:
- Obsessive compulsive disorder (OCD) is a debilitating mental health condition.
- Treatment-resistant OCD poses a significant clinical challenge, necessitating novel therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy of transcranial direct current stimulation (tDCS) as a treatment for individuals with treatment-resistant OCD.
- To assess the response rates and potential benefits of anodal pre-SMA tDCS in this patient population.
Main Methods:
- A retrospective case series analysis of 32 patients diagnosed with treatment-resistant OCD.
- Patients received 10-20 sessions of anodal pre-SMA tDCS.
- Outcomes were assessed based on response criteria at the end of the treatment course.
Main Results:
- A total of 9 out of 32 patients (28%) demonstrated at least a partial response to tDCS.
- Specifically, 8 patients (25%) were classified as responders and 1 patient (3%) as a partial responder.
- Further improvement was observed in partial responders between 10 and 20 sessions.
Conclusions:
- Transcranial direct current stimulation (tDCS) shows potential as an adjunctive therapy for a subset of patients with treatment-resistant OCD.
- These findings suggest that tDCS may offer a viable neuromodulatory option for individuals who have not responded to conventional treatments.
- Further research is warranted to optimize tDCS protocols and identify predictors of response in OCD.

